Checklist Guide: Key Factors in Glucagon Peptide Product Composition
Abstract: Glucagon (abbreviation: GCG) peptide products require rigorous composition analysis for therapeutic efficacy. Current market trends show a 12.3% CAGR (2023-2030) driven by diabetes and obesity applications. Leading brands (e.g., Novo Nordisk, Eli Lilly) differ in purity (>98% vs. 95%) and stability (lyophilized vs. liquid). Technical advantages include rapid glucose mobilization; disadvantages involve short half-life (3-6 min) requiring formulation optimization. Key parameters: molecular weight (3485 Da), pH stability (2-9), and endotoxin limits (<0.5 EU/mg). Product certifications (GMP, USP, ISO 13485) are critical. Selection criteria prioritize supplier audits, cold-chain logistics (2-8°C), and batch consistency. Industry outlook remains robust, with R&D focusing on long-acting analogs.